COYA THERAPEUTICS INC (COYA) Stock Price, Quote, News and Overview
NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
COYA Quote, Performance and Key Statistics
6.88
+0.59 (+9.38%)
The current stock price of COYA is 6.88 USD. In the past month the price decreased by -1.71%. In the past year, price decreased by -26.73%.
COYA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 21.17 | 378.30B | ||
| AMGN | AMGEN INC | 16.39 | 174.51B | ||
| GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
| ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
| ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
| BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
| BIIB | BIOGEN INC | 9.13 | 22.01B | ||
| NTRA | NATERA INC | N/A | 19.02B | ||
| GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
Related stock screener links
About COYA
Company Profile
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company is headquartered in Houston, Texas and currently employs 8 full-time employees. The company went IPO on 2022-12-29. Its initial developmental programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases of high unmet medical need. Its diversified candidate pipeline includes both ex vivo and in vivo approaches. Its product candidate pipeline is based on its three therapeutic modalities. The product candidates utilizing its Treg-enhancing biologics are collectively referred to as the 300 Series. The product candidates utilizing its Treg-derived exosomes are collectively referred to as the 200 Series. The product candidates utilizing its autologous Treg cell therapy are collectively referred to as the 100 Series. The firm's 300 Series product candidates include COYA 301 and COYA 302.
Company Info
COYA THERAPEUTICS INC
5850 San Felipe St., Suite 500
Houston TEXAS US
Employees: 8
Company Website: https://www.coyatherapeutics.com/
Investor Relations: https://ir.coyatherapeutics.com/
Phone: 8005878170
COYA THERAPEUTICS INC / COYA FAQ
What is the stock price of COYA THERAPEUTICS INC today?
The current stock price of COYA is 6.88 USD. The price increased by 9.38% in the last trading session.
What is the ticker symbol for COYA THERAPEUTICS INC stock?
The exchange symbol of COYA THERAPEUTICS INC is COYA and it is listed on the Nasdaq exchange.
On which exchange is COYA stock listed?
COYA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for COYA THERAPEUTICS INC stock?
11 analysts have analysed COYA and the average price target is 15.81 USD. This implies a price increase of 129.8% is expected in the next year compared to the current price of 6.88. Check the COYA THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is COYA THERAPEUTICS INC worth?
COYA THERAPEUTICS INC (COYA) has a market capitalization of 114.96M USD. This makes COYA a Micro Cap stock.
How many employees does COYA THERAPEUTICS INC have?
COYA THERAPEUTICS INC (COYA) currently has 8 employees.
What are the support and resistance levels for COYA THERAPEUTICS INC (COYA) stock?
COYA THERAPEUTICS INC (COYA) has a support level at 6.58 and a resistance level at 7.09. Check the full technical report for a detailed analysis of COYA support and resistance levels.
Is COYA THERAPEUTICS INC (COYA) expected to grow?
The Revenue of COYA THERAPEUTICS INC (COYA) is expected to decline by -11.09% in the next year. Check the estimates tab for more information on the COYA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy COYA THERAPEUTICS INC (COYA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of COYA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of COYA, evaluating the profitability, health, valuation and growth aspects
- COYA THERAPEUTICS INC (COYA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COYA THERAPEUTICS INC (COYA) Sales and EPS estimates to see what analysts future expectations are.
- COYA THERAPEUTICS INC (COYA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COYA THERAPEUTICS INC (COYA) Insider and Institutional Ownership to learn about the owners and their transactions.
- COYA THERAPEUTICS INC (COYA) Stock Chart to make your own analysis
- COYA THERAPEUTICS INC (COYA) Latest news and press-releases to stay up to date.
Does COYA THERAPEUTICS INC (COYA) stock pay dividends?
COYA does not pay a dividend.
When does COYA THERAPEUTICS INC (COYA) report earnings?
COYA THERAPEUTICS INC (COYA) will report earnings on 2025-03-26, before the market open.
What is the Price/Earnings (PE) ratio of COYA THERAPEUTICS INC (COYA)?
COYA THERAPEUTICS INC (COYA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.52).
What is the Short Interest ratio of COYA THERAPEUTICS INC (COYA) stock?
The outstanding short interest for COYA THERAPEUTICS INC (COYA) is 1.77% of its float. Check the ownership tab for more information on the COYA short interest.
COYA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to COYA. When comparing the yearly performance of all stocks, COYA is a bad performer in the overall market: 67.56% of all stocks are doing better.
COYA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to COYA. While COYA has a great health rating, there are worries on its profitability.
COYA Financial Highlights
Over the last trailing twelve months COYA reported a non-GAAP Earnings per Share(EPS) of -0.52. The EPS increased by 43.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.09% | ||
| ROE | -33.42% | ||
| Debt/Equity | 0 |
COYA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to COYA. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of -41.06% and a revenue growth -11.09% for COYA